中国组织工程研究 ›› 2016, Vol. 20 ›› Issue (1): 135-139.doi: 10.3969/j.issn.2095-4344.2016.01.024

• 干细胞综述 stem cell review • 上一篇    

中药诱导骨髓间充质干细胞的定向分化:研究与进展

李 宁1,李应福1,谢兴文2,宋 敏1,徐世红2,李鼎鹏2   

  1. 1甘肃中医药大学,甘肃省兰州市 730000;2甘肃省中医院,甘肃省兰州市 730050
  • 收稿日期:2015-11-16 出版日期:2016-01-01 发布日期:2016-01-01
  • 通讯作者: 李应福,在读硕士,甘肃中医药大学,甘肃省兰州市 730000
  • 作者简介:李宁,女,1974年生,河南省开封市人,汉族,博士,副教授,硕士生导师,主要从事中医药对骨关节疾病的研究。
  • 基金资助:
    国家自然科学基金资助项目(81460735);甘肃省自然科学基金项目(1010RJZA217)

Directional differentiation of bone marrow mesenchymal stem cell induced by traditional Chinese Medicine

Li Ning1, Li Ying-fu1, Xie Xing-wen2, Song Min1, Xu Shi-hong2, Li Ding-peng2   

  1. 1Gansu University of Chinese Medicine, Lanzhou 730000, Gansu Province, China; 2Gansu Provincial Hospital of TCM, Lanzhou 730050, Gansu Province, China
  • Received:2015-11-16 Online:2016-01-01 Published:2016-01-01
  • Contact: Li Ying-fu, Studying for master’s degree, Gansu University of Chinese Medicine, Lanzhou 730000, Gansu Province, China
  • About author:Li Ning, M.D., Associate professor, Master’s supervisor, Gansu University of Chinese Medicine, Lanzhou 730000, Gansu Province, China
  • Supported by:

    the National Natural Science Foundation of China, No. 81460735; the Natural Science Foundation of Gansu Province, No. 1010RJZA217

摘要:

文章快速阅读:

文题释义:

细胞分化:在个体发育过程中,细胞分化是程序控制的有序有规律过程,程序的运行结果表现为不同发育阶段、不同组织部位的细胞表现出不同的形态、不同的生长方式和不同的生理功能。从分子水平上来看,这一结果取决于细胞在基因表达上的时空差异。这种基因表达差异除由细胞内在发育程序决定外,还受细胞外环境影响和调控,且有时这种外部控制条件或环境对形成特定细胞有着决定性作用。

含药血清实验:近年来,含药血清实验方法开始引起越来越多研究者的重视。对于含药血清的制备方法,一般认为药物和观察指标不同,需要首先对含药血清的时效和量效进行研究,以便确定给药剂量、采血时间、含药血添加浓度等含药血清的制备和实验条件。

 

背景:近年来,对传统单味中药或提取物、复方中药及含药血清调控骨髓间充质干细胞定向分化为肌成纤维细胞、软骨细胞、成骨细胞、心肌细胞、神经细胞等研究的不断深入,使中药或其提取物对骨髓间充质干细胞增殖、调控定向分化和移植等方面成为组织工程研究领域的一大亮点。
目的:综述中药或其提取物诱导骨髓间充质干细胞定向分化的最新研究进展。
方法:分别以“中药,定向分化,骨髓间充质干细胞”,“Chinese herb,directional differentiation, mesenchymal stem cells”为检索词,由第一作者检索2010年1月至2016年1月中国期刊全文数据库、PubMed数据库及万方数据库相关文章。排除缺乏原创性及重复性研究的文献,计算机初检到99篇文献,最终保留43篇进行归纳总结。
结果与结论:骨髓间充质干细胞作为骨分化系统中最强的种子细胞,具有广泛的定向分化潜能,与传统中草药结合在临床治疗众多难治性疾病中凸显重要价值,尤其对于治疗骨代谢疾病、骨缺损、骨折不愈合及迟缓愈合等疾病更加充分发挥其临床应用价值,这既有利于进一步深层次,多角度研究中药的作用及发生机制,也使骨髓间充质干细胞向更宽、更广领域参与临床各类难治性疾病的治疗。
 
ORCID: 0000-0003-1212-1881(李应福)

关键词: 干细胞, 培养, 中药, 骨髓间充质干细胞, 诱导分化, 研究进展, 骨伤疾病, 国家自然科学基金

Abstract:

BACKGROUND: In recent years, in-depth studies that single Chinese herbs or extracts, compound traditional Chinese medicine and medicated serum are used to regulate the directional differentiation of bone marrow mesenchymal stem cells into myofibroblasts, chondrocytes, osteoblasts, myocardial cells and nerve cells, which have become a highlight in the tissue engineering research.
OBJECTIVE: To review the latest progress in the directional differentiation of bone marrow mesenchymal stem cells induced by Chinese herbs or their extracts.
METHODS: The first author searched the CNKI, Wanfang and PubMed databases using the keywords of “Chinese herb, directional differentiation, mesenchymal stem cells” in Chinese and English, respectively, to retrieve relevant articles published from January 2010 to January 2016. Repetitive articles or those with no originality were eliminated. Totally 99 articles were searched initially, and then 43 articles were included in result analysis.
RESULTS AND CONCLUSION: As the strongest seed cells in the bone differentiation system, bone marrow mesenchymal stem cells have a wide range of directional differentiation potential, and highlight the important value in combination with Chinese herbs for clinical treatment of various refractory diseases, especially for treatment of metabolic bone diseases, bone defects, nonunion and delayed union, which is not only conducive to in-depth, multi-angle studies on effects and mechanisms of Chinese herbs, but also to clinical treatment of various refractory diseases using bone marrow mesenchymal stem cells.